EP Patent

EP3586641A1 — Dha enriched polyunsaturated fatty acid compositions

Assigned to Nuseed Pty Ltd · Expires 2020-01-01 · 6y expired

What this patent protects

There is provided a vegetable-based lipid composition comprising high levels of at least three different long-chain polyunsaturated fatty acids (typically as fatty acid esters). The compositions typically contain DHA as the principal long-chain polyunsaturated fatty acid. The com…

USPTO Abstract

There is provided a vegetable-based lipid composition comprising high levels of at least three different long-chain polyunsaturated fatty acids (typically as fatty acid esters). The compositions typically contain DHA as the principal long-chain polyunsaturated fatty acid. The composition is obtainable from a single source by conventional processing methods, and has improved stability properties.

Drugs covered by this patent

Patent Metadata

Patent number
EP3586641A1
Jurisdiction
EP
Classification
—
Expires
2020-01-01
Drug substance claim
No
Drug product claim
No
Assignee
Nuseed Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.